GZMA
Basic information
Region (hg38): 5:55102646-55110252
Previous symbols: [ "HFSP", "CTLA3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (32 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GZMA gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006144.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 28 | 4 | 1 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GZMA | protein_coding | protein_coding | ENST00000274306 | 5 | 7605 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000205 | 0.280 | 125625 | 0 | 22 | 125647 | 0.0000876 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.169 | 136 | 142 | 0.960 | 0.00000687 | 1705 |
Missense in Polyphen | 59 | 54.164 | 1.0893 | 664 | ||
Synonymous | 0.795 | 43 | 50.2 | 0.857 | 0.00000263 | 520 |
Loss of Function | 0.183 | 9 | 9.61 | 0.936 | 4.69e-7 | 122 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000182 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000219 | 0.000218 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000106 | 0.000106 |
Middle Eastern | 0.000219 | 0.000218 |
South Asian | 0.0000980 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Abundant protease in the cytosolic granules of cytotoxic T-cells and NK-cells which activates caspase-independent cell death with morphological features of apoptosis when delivered into the target cell through the immunological synapse. It cleaves after Lys or Arg. Cleaves APEX1 after 'Lys-31' and destroys its oxidative repair activity. Cleaves the nucleosome assembly protein SET after 'Lys-189', which disrupts its nucleosome assembly activity and allows the SET complex to translocate into the nucleus to nick and degrade the DNA. {ECO:0000269|PubMed:11555662, ECO:0000269|PubMed:12524539, ECO:0000269|PubMed:12628186, ECO:0000269|PubMed:16818237}.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);granzyme a mediated apoptosis pathway;tsp-1 induced apoptosis in microvascular endothelial cell;IL12-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.0673
Intolerance Scores
- loftool
- 0.494
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.32
Haploinsufficiency Scores
- pHI
- 0.105
- hipred
- N
- hipred_score
- 0.147
- ghis
- 0.429
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.192
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gzma
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; neoplasm; immune system phenotype;
Gene ontology
- Biological process
- apoptotic process;immune response;response to bacterium;cytolysis;negative regulation of endodeoxyribonuclease activity;positive regulation of apoptotic process;negative regulation of DNA binding;negative regulation of oxidoreductase activity;proteolysis involved in cellular protein catabolic process
- Cellular component
- immunological synapse;extracellular region;nucleus
- Molecular function
- serine-type endopeptidase activity;protein binding;protein homodimerization activity